1. Introduction {#s0005}
===============

Paget\'s disease of bone (PDB) is a chronic focal skeletal disorder that affects 2 to 3% of the population over the age of 55 years. The primary pathologic abnormality in PDB resides in bone resorbing osteoclast (OCL) cells. Patients with PDB have an incidence of developing osteosarcoma in an affected bone ([@bb0045]). PDB is an autosomal dominant trait with genetic heterogeneity and incomplete penetrance ([@bb0090]). Mutations in gene encoding p62 (sequestosome 1/SQSTM1) have been identified in 5 to 10% of total patients with PDB ([@bb0025]). Paramyxoviral-nuclear inclusions have been identified in 20--40% of OCL in these patients ([@bb0145], [@bb0115]). Immunohistochemical studies have confirmed the presence of measles virus (MV) and respiratory syncytial virus (RSV) nucleocapsids in pagetic OCLs ([@bb0120], [@bb0150]). Furthermore, measles virus nucleocapsid (MVNP) transcripts have been detected in \> 80% of bone marrow samples from patients with PDB ([@bb0035]). Also, MVNP expression has been detected in pagetic osteosarcomas ([@bb0110]). These findings implicated environmental factors such as MV play an important role in pathogenesis of PDB. Previously, canine distemper virus (CDV) nucleocapsid transcripts were also detected in pagetic bone samples ([@bb0105]). However, others have been unable to detect the expression of paramyxoviral transcripts in PDB ([@bb0050], [@bb0095]). Despite of viral etiology, no infectious virus is isolated from these patients.

Receptor activator of NF-κB ligand (RANKL) and RANK signaling is critical for OCL differentiation and function. RANKL interaction with RANK results in recruitment of TNF receptor-associated factor (TRAF) proteins and activation of NF-κB, c-Fos, c-Jun N-terminal kinase (JNK) during OCL differentiation ([@bb0015]). Also, RANKL signaling induces nuclear factor of activated T cells, cytoplasmic 1 (NFATc1) which regulates OCL gene expression ([@bb0200]). RANKL costimulatory signaling with immunoreceptor tyrosine-based activation motif (ITAM) bearing adapter molecules such as DAP12 activates calcium signaling and NFATc1 critical for OCL differentiation ([@bb0130]). RANK signaling has also been shown to induce dendritic cell specific transmembrane protein (DC-STAMP) which plays an essential role in fusion of preosteoclast cells to form multinucleated OCLs ([@bb0065]). We previously demonstrated that MVNP expression in preosteoclast cells induces pagetic OCL differentiation ([@bb0075]). Previously, we have shown that MVNP stimulate the expression of ASK1, Rac1, c-Fos, p-JNK, and NFATc1 during OCL differentiation ([@bb0165]). However, the molecular mechanisms that regulate pagetic OCL formation and bone resorption activity in the PDB are unclear.

Signal regulatory proteins (SIRPs) are transmembrane glycoproteins that are expressed in hematopoietic cells including macrophages, monocytes, granulocytes and dendritic cells ([@bb0060]). SIRPs are characterized by containing three Ig like domains with different transmembrane and cytoplasmic domains ([@bb0140]). Signal regulatory proteins classified into SIRPα and SIRPβ based on cytoplasmic domains. SIRPα has been shown to inhibit OCL differentiation and bone resorption ([@bb0215]). SIRPβ1 (CD172b) is a transmembrane protein, which contains three Ig like domains in the extracellular region and a short cytoplasmic domain ([@bb0160]). SIRPβ1 contains lysine residue within the hydrophobic transmembrane domain which interacts with DAP12. Previously, Zou et al. ([@bb0245]) have reported that DAP12 knock-out mice show defective in osteoclastogenesis and cytoskeleton organization. SIRPβ1 signaling has been shown to activate the MAP kinase pathway which regulates various cellular functions ([@bb0210], [@bb0030]). However, the MVNP regulation of SIRPβ1 and a functional role in OCL differentiation in the PDB is unknown. In this study, we showed that MVNP modulates SIRPβ1 which play an important role in the enhanced OCL differentiation and bone resorption activity associated with PDB.

2. Materials and methods {#s0010}
========================

2.1. Reagents and antibodies {#s0015}
----------------------------

Cell culture and DNA transfection reagent, lipofectamine were purchased from Invitrogen Inc. (Carlsbad, CA). Normal primary human bone marrow mononuclear cells were purchased from ATCC (Manassas, VA) and peripheral blood monocytes (PBMC) were obtained from Stem Cell Technologies Inc., (Vancouver, BC). RANKL and M-CSF were obtained from R&D systems Inc. (Minneapolis, MN). *Anti*-c-Fos, *anti*-SIRPβ1 and peroxidase-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). *Anti*-DAP12, Syk and p-Syk antibodies were obtained from the Cell Signaling (Danvers, MA). SuperSignal enhanced chemiluminescence (ECL) reagent was purchased from the Amersham Bioscience (Piscataway, NJ), and nitrocellulose membranes were from Millipore (Bedford, MA).

2.2. Retroviral expression of MVNP {#s0020}
----------------------------------

We have previously developed a retroviral plasmid construct, pILXAN\#1 that transcribes MVNP mRNA expression under the control of a 5′ LTR viral promoter. The recombinant retroviral plasmid construct was transiently transfected into the PT67 packaging cell line using the lipofectamine. The stable cell lines were established by selecting for resistance to neomycin (600 μg/ml). Similarly, a control retrovirus producer cell line was established by transfecting cells with the pLXSN empty vector (EV). Normal human bone marrow derived mononuclear cells and PBMC were transduced with EV or MVNP retroviral supernatants (20%) from the producer cell lines in the presence of polybrene (4 μg/ml) for 24 h at 37 °C in a 5% CO~2~ incubator as described earlier ([@bb0075]).

2.3. Lentiviral expression of SIRPβ1 shRNA {#s0025}
------------------------------------------

A human GIPZ lentiviral SIRPβ1 shRNAmir (Thermo Scientific Open Biosystem, Huntsville, AL) recombinant plasmid construct was transfected into the 293T amphotropic packaging cell line using lipofectamine. Stable clonal cell line producing SIRPβ1 shRNAmir recombinant lentivirus at high titer (1 × 10^6^ virus particles/ml) was established by selecting for resistance to puromycin (1.5 μg/ml). Similarly, a control lentivirus producer cell line was established by transfecting the cells with the GIPZ lentiviral empty vector (EV). The producer cell line was maintained in DMEM containing 10% FBS, 100 U/ml each of streptomycin and penicillin, 4 mM L-glutamine and high glucose (4.5 g/L). Lentiviral transduction into the human bone marrow derived mononuclear cells and PBMC were performed as described above.

2.4. Microarray analysis {#s0030}
------------------------

Human bone marrow derived mononuclear cells were transduced with EV, MVNP and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA was isolated using RNAzol reagent (Biotecx Labs, Houston, TX) and subjected to Agilent whole genome 4 K × 44 K array analysis of ∼ 26,000 genes. Agilent feature extraction and GeneSpring GX v7.3.1 software packages (Genus Biosystem, Inc. Northbrook, IL) were employed to analyze the data. Gene Ontology Tree Machine (GOTM) is a web-based platform used for interpreting gene expression profile of microarray data ([@bb0235]).

2.5. Western blot analysis {#s0035}
--------------------------

Normal bone marrow derived mononuclear cells were transduced with MVNP in the presence and absence of SIRPβ1 shRNA and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for indicated time point. Total cell lysates were prepared in a lysis buffer (20 mM Tris--HCl, pH 7.4, 1% Triton X-100, 1 mM EDTA, 1.5 mM MgCl~2~; 10% glycerol, 150 mM NaCl, 0.1 mM Na~3~VO~4~ ) containing 1 × protease inhibitor cocktail. The protein content of the samples was measured using the BCA protein assay reagent (Pierce, Rockford, IL). Protein (30 μg) samples were then subjected to SDS--PAGE (4--15% Tris--HCl gradient gels) and blot transferred onto a PVDF membrane, immunoblotted with *anti*-c-Fos, *anti*-Syk, *anti*-phospho-Syk (p-Syk) and *anti*-β-actin antibodies. The bands were detected using the ECL and the intensity was quantified by densitometry using the NIH ImageJ Program.

2.6. Co-Immunoprecipitation assay {#s0040}
---------------------------------

Human bone marrow mononuclear cells were transduced with EV or MVNP in the presence and absence of M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total cell lysates collected in a lysis buffer (50 mm HEPES (pH 7.5), 250 mm NaCl, 10 μm NaF, 0.2 mm EDTA and 0.5% Nonidet P-40) and were subjected to immunoprecipitation using *anti*-DAP12 antibody or control IgG overnight at 4 °C. The immune complexes were captured upon incubation with 100 μl of protein A agarose beads (Sigma, St. Louis, MO) for 2 h at 4 °C and subjected to western blot analysis using anti-SIRPβ1 antibody as described earlier ([@bb0185]).

2.7. Real-time RT-PCR analysis of mRNA expression {#s0045}
-------------------------------------------------

Bone marrow mononuclear cells were derived from patients with PDB and normal. All human samples were obtained following the IRB approved protocol at the Medical University of South Carolina. Briefly, 15 ml of bone marrow sample was mixed equal volume of α-MEM and layered over 15 ml of Ficoll-Paque (Sigma, MO) and centrifuged (1500 ×* g*, 30 min) at room temperature. The cell layer on top of the Ficoll-Paque was collected and washed with α-MEM. The resulting mononuclear cells were used for further studies. Cells were transduced with EV or MVNP with and without SIRPβ1 shRNA and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA was isolated from these cells using RNAzol. The reverse transcription reaction was performed using a iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) at 25 °C for 5 min, 42 °C for 30 min followed by 85 °C for 5 min. The quantitative real-time PCR was performed using IQ™ SYBR Green Supermix in an iCycler and the primers specific for SIRPβ1 sense 5′-GCA GGG CTC AAA TAC TGC TC-3′ and antisense 5′-GAC AGA GAC ACC AAC CAC CA-3′; DC-STAMP sense 5′-TCG TCA TCT TGG GAC ACG TA-3′ and antisense 5′-TGG AAA ATG TAT GGA AAA GCT C-3′; CTGF sense 5′-CAG CAG AAA GGT TAG TAT CAT CAG A-3′ and antisense 5′-CCT AGC TGT CAC TGG GGC TA-3′; and GAPDH sense 5′-CCT ACC CCC AAT GTA TCC GTT GTG-3′ and antisense 5′-GGA GGA ATG GGA GTT GCT GTT GAA-3′. Thermal cycling parameters were 94 °C for 3 min, followed by 40 cycles of amplifications at 94 °C for 30 s, 60 °C for 1 min, 72 °C for 1 min, and 72 °C for 5 min as the final elongation step as described earlier ([@bb0195]). The mRNA expression was normalized with respect to GAPDH amplification.

2.8. Osteoclast differentiation and bone resorption activity assay {#s0050}
------------------------------------------------------------------

Normal human Peripheral blood mononuclear cells (PBMC) were isolated as described earlier ([@bb0165]). PBMC (6 × 10^5^) was plated in 96-well plates per well in 0.2 ml alpha-MEM medium and supplemented with hRANKL (100 ng/ml), hM-CSF (10 ng/ml) and 1 μM dexamethasone. At the end of the culture period (10 days) the cells were fixed with 2% glutaraldehyde in PBS and stained for tartrate resistant acid phosphatase (TRAP) activity using a histochemical kit (Sigma, St Louis, MO). TRAP positive multinucleated cells (MNC) containing three or more nuclei were scored as OCL under a microscope. Bone resorption activity of the OCLs was assayed by culturing cells for 10 days on sterile dentine slices as described ([@bb0165]). The cells on dentine slices were removed using 1 M NaOH and stained with 0.1% toluidine blue. The bone resorption area was quantified using computerized image analysis (Adobe Photoshop and Scion MicroImaging version 4.2). The percentage of the resorbed area was calculated relative to the total dentine disc area.

2.9. Statistical analysis {#s0055}
-------------------------

Data obtained from three independent experiments is presented as mean ± SD and were compared by Student\'s *t*-test. Values were considered significant at p \< 0.05.

3. Results {#s0060}
==========

3.1. MVNP upregulation of SIRPβ1 expression {#s0065}
-------------------------------------------

MVNP has been shown to play an important role in pathogenesis of PDB ([@bb0080]). However, the molecular mechanism underlying MVNP induction of pagetic OCLs is unclear. Therefore, to determine the MVNP modulated gene expression profile during OCL differentiation, we transduced retroviral expression of MVNP in normal human bone marrow derived mononuclear cells and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA isolated from these cells was subjected to Agilent microarray analysis as described in Methods. Gene cluster analysis and scatter plot of MVNP regulated gene expression profiling demonstrated 8.4% of genes were upregulated (\> 4-fold) in MVNP transduced cells compared to EV ([Fig. 1](#f0005){ref-type="fig"}). The data were deposited in the Gene Expression Omnibus (GEO) database repository at NCBI (Accession \# GSE29106). We thus identified MVNP transduced cells show a very high level of SIRPβ1 (353-fold) expression in these cells. To further validate the MVNP regulated SIRPβ1 expression, total RNA isolated from normal human bone marrow derived mononuclear cells transduced with MVNP or EV stimulated with M-CSF and RANKL for 48 h was subjected to real-time-RT-PCR analysis. As shown in [Fig. 2](#f0010){ref-type="fig"}A, MVNP increased (35-fold) the SIRPβ1 mRNA expression compared to EV transduced cells. We also confirmed SIRPβ1 mRNA expression was elevated (130 fold) in bone marrow mononuclear cells obtained from patients with PDB (n = 4) compared to normal subjects ([Fig. 2](#f0010){ref-type="fig"}B). Taken together, our results indicate that MVNP induce SIRPβ1 expression which may have an important functional role in pathogenesis of PDB.Fig. 1Microarray profiling of gene expression in control empty vector (EV) and MVNP transduced normal human bone marrow derived mononuclear cells. Cells transduced with EV and MVNP retroviral vectors and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA isolated from these cells were subjected to Agilent whole genome 4K × 44K array system for microarray analysis for \~ 26,000 genes revealed differential gene expression in MVNP transduced cells by (A) cluster analysis and (B) scatter plot. Gene expression profile presented as: red --- high expression; yellow --- medium expression; blue --- low expression.Fig. 1Fig. 2MVNP induces SIRPβ1 in normal human bone marrow derived mononuclear cells. (A) Cells were transduced with EV or MVNP retroviral expression plasmid and stimulated with and without M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA isolated was subjected to real-time RT-PCR analysis for SIRPβ1 expression. (B) SIPRβ1 mRNA expression in patients with PDB. Total RNA isolated from normal (n = 5) and Paget\'s patients (n = 4) bone marrow cells were subjected to real-time RT-PCR analysis for SIRPβ1 mRNA expression. The relative level of mRNA expression was normalized by GAPDH amplification. The values are expressed as mean ± SD for three independent experiment (\*p \< 0.05).Fig. 2

3.2. SIRPβ1 signaling in preosteoclast cells {#s0070}
--------------------------------------------

SIRPβ1 is a transmembrane glycoprotein associated with an adaptor molecule DAP12 in hematopoietic cells ([@bb0060]). Therefore, to examine MVNP modulates SIRPβ1 interaction with DAP12 in preosteoclast cells, we transduced MVNP retroviral expression plasmid into the human bone marrow derived mononuclear cells and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total cell lysates obtained from these cells were subjected to immunoprecipitation analysis using *anti*-DAP12 antibody. The immunoprecipitant was subjected to western blot analysis for SIRPβ1 expression. As shown in [Fig. 3](#f0015){ref-type="fig"}A, MVNP significantly increased SIRPβ1 interaction with DAP12 with and without RANKL stimulation in these cells. Spleen tyrosine kinase (Syk) is an adaptor molecule for DAP12 ([@bb0070]). Therefore, we further examined the SIRPβ1 participation in the activation of Syk in preosteoclast cells. We transduced MVNP with and without a SIRPβ1 shRNA into human bone marrow mononuclear cells and stimulated with RANKL (100 ng/ml) for 24 h. Total cell lysates obtained from these cells were subjected to western blot analysis for p-syk and syk. We identified that MVNP increased p-syk (4.2-fold) compared to EV transduced cells ([Fig. 3](#f0015){ref-type="fig"}B). Further, shRNA suppression of SIRPβ1 significantly decreased MVNP elevated p-syk level in these cells. In addition, shRNA knockdown of SIRPβ1 inhibits MVNP stimulated c-Fos expression in these cells ([Fig. 4](#f0020){ref-type="fig"}A).Fig. 3MVNP regulation of SIRPβ1 signaling in preosteoclast cells. (A) MVNP enhances SIRPβ1 interaction with DAP12 in normal human bone marrow mononuclear cells. Cells were transduced with EV or MVNP and stimulated with and without M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total cell lysates obtained from these cells were subjected to immunoprecipitation using *anti*-DAP12 or control IgG antibodies. Immunoprecipitants were subjected to western blot analysis for SIRPβ1. Total DAP12 expressions in these cells were served for loading control. (B) shRNA suppression of SIRPβ1 inhibits MVNP increased p-syk expression. Normal human bone marrow derived mononuclear cells were transduced with EV or MVNP in the presence and absence of SIRPβ1 shRNA and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 24 h. Total cell lysates were subjected to western blot analysis for p-syk and syk expression.Fig. 3Fig. 4SIRPβ1 participation in MVNP regulated gene expression during OCL differentiation. (A) shRNA suppression of SIRPβ1 inhibits MVNP enhanced c-Fos expression. Normal human bone marrow derived mononuclear cells were transduced with MVNP in the presence and absence of SIRPβ1 shRNA or control shRNA and stimulated with M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total cell lysates were subjected to western blot analysis for c-Fos expression. (B) SIRPβ1 shRNA suppression decreases DC-STAMP and CTGF mRNA expression. Human bone marrow derived mononuclear cells were transduced with EV or MVNP in the presence of control or SIRPβ1 shRNA and cultured for 48 h with RANKL and M-CSF. Total RNA isolated from these cells was subjected to real-time RT-PCR analysis for DC-STAMP and CTGF mRNA expression. The level of mRNA expression was normalized with GAPDH amplification. The values are expressed as mean ± SD for three independent experiments (p \< 0.05). \*Compared with EV; \#compared with control shRNA or MVNP.Fig. 4

DC-STAMP, a cell fusion protein plays an important role in the formation of multinucleated OCLs ([@bb0230]). Recently, it has been shown that connective tissue growth factor (CTGF) interaction with DC-STAMP promotes osteoclastogenesis ([@bb0135]). Therefore, we next examined the effect of SIRPβ1 on DC-STAMP and CTGF expression in preosteoclast cells. We transduced MVNP with and without SIRPβ1 shRNA expression plasmids into bone marrow mononuclear cells and stimulated with MCSF (10 ng/ml) and RANKL (100 ng/ml) for 48 h. Total RNA isolated from these cells was subjected to real-time RT-PCR analysis for DC-STAMP and CTGF mRNA expression. As shown in [Fig. 4](#f0020){ref-type="fig"}B, MVNP increased DC-STAMP (3.0-fold) and CTGF (5.0-fold) mRNA expression compared to EV transduced cells. In addition, SIRPβ1 knockdown significantly decreased MVNP stimulated DC-STAMP and CTGF mRNA expression in these cells. These results suggest that MVNP modulation of SIRPβ1 signaling may play an important role in enhanced OCL differentiation in PDB.

3.3. SIRPβ1 participation in MVNP enhanced osteoclast differentiation and bone resorption {#s0075}
-----------------------------------------------------------------------------------------

Since MVNP regulated SIRPβ1 signaling molecules, we further determined the participation of SIRPβ1 in MVNP induced OCL formation and bone resorption activity. PBMC transduced with EV or MVNP and SIRPβ1 shRNA were cultured in the presence of M-CSF (10 ng/ml) and RANKL (100 ng/ml) for 10 days. Inconsistent with the previous findings, MVNP markedly increased the size and number of OCL formation ([Fig. 5](#f0025){ref-type="fig"}A). Interestingly, SIRPβ1 knockdown inhibits MVNP enhanced OCL formation. We next examined the potential of SIRPβ1 in OCL bone resorption activity. SIRPβ1 suppression in MVNP transduced cells demonstrated a significant inhibition of resorption lacunae on dentine slices compared to MVNP alone transduced cultures ([Fig. 5](#f0025){ref-type="fig"}B). Thus, our results suggest that SIRPβ1 contributes to MVNP escalated OCL differentiation/resorption activity in PDB.Fig. 5SIRPβ1 shRNA inhibition of MVNP stimulated OCL differentiation in normal human peripheral blood monocyte (PBMC) culture. (A) Human PBMCs were transduced with EV or MVNP in the presence of control or SIRPβ1 shRNA and stimulated with RANKL (100 ng/ml) and M-CSF (10 ng/ml) for 10 days. The TRAP (+) multinucleated OCLs formed in these cultures was scored. (B) Bone resorption activity of OCLs on dentine. The percentage of resorbed area on dentine was measured as described in *Methods*. The values are expressed as mean ± SD of three independent experiments (p \< 0.05). \*Compared with EV; \#compared with control shRNA or MVNP.Fig. 5

4. Discussion {#s0080}
=============

Several costimulatory factors associated with immune signaling have been shown to play an essential role in OCL differentiation ([@bb0070]). In this study, microarray analysis demonstrated the pathological significance of MVNP through induction of SIRPβ1 signaling molecule expression in preosteoclast cells. Our findings are consistent that bone marrow monocytes derived from patients with PDB also showed elevated levels of SIRPβ1 expression. These results suggested that MVNP modulation of SIRPβ1 may have a functional significance in PDB. MVNP induced IL-6 in association with widely occurred p62 mutation (P392L) has been shown to contribute to the pathogenesis of PDB suggested that interaction of both viral and genetic factors may play a role in disease severity ([@bb0085], [@bb0170]). Genome-wide association studies on PDB have further identified OPTN, CSF1 and TNFRSF11A gene loci ([@bb0005]). Therefore, genetic abnormalities associated with PDB might influence SIRPβ1 to modulate OCL activity and disease susceptibility. It has been reported that murine macrophage cells persistently infected with RSV showed the altered gene expression profile of cytokines, transmembrane proteins and cell survival ([@bb0155]). Though the paramyxo-viruses could alter cellular gene expression profile, a functional role for MVNP modulation of SIRPβ1 signaling is evident through enhancing the interaction with DAP12 which play an important role in OCL differentiation. Previously, it has also been shown that SIRPβ1 interaction with DAP12 is involved in cellular activation ([@bb0030]). Further, Syk kinase activation is associated with multiple biological functions, including OCL bone resorption ([@bb0125], [@bb0240]). This study demonstrated that SIRPβ1 mediates MVNP induced Syk activation during OCL differentiation.

The c-Fos is essential for OCL differentiation and expressed at high levels in pagetic OCLs ([@bb0010]). It has also been reported that Fos related protein Fra-2 deficiency results in giant OCL formation in mice and that leukemia inhibitory factor (LIF) signaling is critical in this process ([@bb0020]). We previously demonstrated that MVNP stimulate c-Fos expression during OCL differentiation ([@bb0165]). This study further show that SIRPβ1 knockdown suppress MVNP induced c-Fos expression suggesting a functional role for SIRPβ1 in MVNP induced pagetic OCL development. It has been shown that both MVNP and mutant p62 expression results in OCL precursors hyper-sensitive to RANKL and TNF-α. In addition, MVNP also sensitizes the cells to vitamin D3 ([@bb0040]). We show that SIRPβ1 participates in MVNP induced c-Fos expression as down-stream effector of RANK signaling. Therefore, these results suggest that SIRPβ1 may as well contribute to the hyper-responsivity of OCL precursors to RANKL and vitamin D3. CTGF expressed in preosteoclast cells has been shown to induce and interact with DC-STAMP to promote osteoclastogenesis ([@bb0135]). Therefore, our findings that SIRPβ1 silencing inhibit both CTGF and DC-STAMP expression further attests a functional role for SIRPβ1 in MVNP enhanced OCL differentiation in PDB. Preosteoclast fusion is described as a heterogeneous process. Molecules such as OC-STAMP and syncytin-1 retroviral fusion protein have also been implicated in osteoclast precursor fusion ([@bb0055], [@bb0225]). Therefore, it is possible that MVNP expression or SIRPβ1 signaling may regulate other molecules involved in OCL precursor\'s fusion process. Interestingly, SIRPβ1 knockdown only affected the MVNP enhanced OCL formation, size and expression of fusion molecules DC-STAMP and CTGF. However, there was no significant change in the empty vector transduced control cells. This suggests that SIRPβ1 may not be necessary for basal osteoclastogenesis in vitro because there may be other co-receptors available for DAP12. These findings further suggest that upregulation of SIRPβ1 might play a role in other pathologies with inflammatory enhancement of osteoclasts formation.

In contrast, MVNP expression has been shown to decrease FoxO3/Sirt1 signaling to enhance the levels of IL-6 production in pagetic OCLs contributing to the pathogenesis of PDB ([@bb0220]). Also, TBK1 (TANK-binding kinase 1) has been shown to mediate the effects of MVNP to induce IL-6 expression and pagetic OCL differentiation ([@bb0175]). More recently, it has been demonstrated that MVNP induction of IL-6 in OCL cells results in elevated levels of IGF-1 which in turn increases the expression of coupling factors, ephrinB2 on OCLs and EphB4 on osteoblasts, thereby enhancing the OCL driven osteoblast activity in PDB ([@bb0205]). Earlier, we showed that patients with PDB contain elevated levels of FGF-2 and chemokine CXCL5 which modulates osteoclastogenesis through induction of RANKL expression in osteoblast cells ([@bb0180], [@bb0190]). Therefore, MVNP regulation of SIRPβ1 signaling in OCL cells could modulate secretory factors which influence OCL/osteoblast activity. Signaling molecules such as Akt and ERK have been shown to be activated in pagetic OCLs and that phospho-inositide dependent kinase 1 (PDK1) regulate this process and autophagy ([@bb0100]). However, we show that SIRPβ1 suppression inhibits MVNP induced OCL development and bone resorption activity further attests SIRPβ1functional role in pathogenesis of PDB. Thus, MVNP regulation of SIRPβ1 provides new insights into the molecular mechanisms which control the enhanced OCL formation and high bone turnover in PDB.
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